1. Home
  2. SITM vs CYTK Comparison

SITM vs CYTK Comparison

Compare SITM & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiTime Corporation

SITM

SiTime Corporation

HOLD

Current Price

$365.90

Market Cap

9.1B

Sector

Technology

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.63

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SITM
CYTK
Founded
2003
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.0B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
SITM
CYTK
Price
$365.90
$62.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
15
Target Price
$325.63
$77.87
AVG Volume (30 Days)
389.8K
1.8M
Earning Date
02-04-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$281,486,000.00
$87,211,000.00
Revenue This Year
$52.14
$361.33
Revenue Next Year
$44.15
$65.14
P/E Ratio
N/A
N/A
Revenue Growth
59.04
2609.26
52 Week Low
$105.40
$29.31
52 Week High
$387.52
$69.33

Technical Indicators

Market Signals
Indicator
SITM
CYTK
Relative Strength Index (RSI) 64.13 48.91
Support Level $357.31 $59.56
Resistance Level $387.52 $67.26
Average True Range (ATR) 18.94 2.36
MACD 6.01 -0.67
Stochastic Oscillator 83.66 33.98

Price Performance

Historical Comparison
SITM
CYTK

About SITM SiTime Corporation

SiTime Corp is a provider of silicon timing systems solutions. The company designs develops and sell silicon timing systems solutions for different industries including automotive, infrastructure, aerospace-defense, consumer, internet of things, consumer and industrials. Its product offerings include Stratum 3E DCOCXOs, Programmable OCXOs, MHz Oscillators, 32.768 kHz Oscillators, Embedded Resonators, Precision MHz Super-TCXOs, and Ruggedized Oscillators. It sells its products around Taiwan, Hong Kong, the United States, and other regions and generates the majority of its revenue from Taiwan.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: